PMID: 9548609Apr 21, 1998Paper

Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis

Seminars in Surgical Oncology
P H Sugarbaker

Abstract

Intraperitoneal chemotherapy and cytoreductive surgery have been combined to reach treatment objectives in patients with peritoneal carcinomatosis or sarcomatosis that neither modality by itself can achieve. These treatments must be combined with the proper selection of patients in order to observe "high value" results from therapy. There are three principles of management to support treatments for peritoneal carcinomatosis and sarcomatosis. First, the clinician must select patients who have isolated disease distributed on the surfaces of abdominal and pelvic structures. Patients treated for peritoneal implants who have persistent disease at other sites will profit little or not at all. Second, this disease must be reduced to its lowest possible mass by peritonectomy procedures and resections of viscera. Third, maximal intraperitoneal and systemic chemotherapy are utilized to eradicate the disease on peritoneal surfaces as well as control the primary or recurrent tumor. These principles of management and a presentation of the results achieved to date are reviewed.

Associated Clinical Trials

Dec 19, 2014·Michael Bau Mortensen

References

Jul 1, 1995·Holistic Nursing Practice·S Hartman
Jan 1, 1995·Annals of Surgery·P H Sugarbaker
Jun 1, 1996·World Journal of Surgery·P H SugarbakerM von Meyerfeldt
Jan 1, 1996·Cancer Treatment and Research·P Jacquet, P H Sugarbaker
Jan 1, 1996·Cancer Treatment and Research·A M Averbach, P H Sugarbaker
Jan 1, 1996·Cancer Treatment and Research·P Jacquet, P H Sugarbaker
Jan 1, 1996·Cancer Treatment and Research·P H Sugarbaker
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B BerthetP H Sugarbaker

❮ Previous
Next ❯

Citations

Jul 27, 2001·Journal of Surgical Oncology·P H Sugarbaker
Oct 29, 2000·Diseases of the Colon and Rectum·S R Pestieau, P H Sugarbaker
Oct 29, 2000·Diseases of the Colon and Rectum·S González-Moreno, P H Sugarbaker
Nov 16, 2007·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·D Arnold, F Lordick
Sep 18, 2012·European Journal of Clinical Pharmacology·P H CashinH Mahteme
Nov 3, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F C Muñoz-CasaresA Gómez-Portilla
Nov 18, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Francisco C Muñoz-CasaresJordi Muntané
Jun 11, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Pedro Bretcha-BoixAntonio Brugarolas Masllorens
Apr 6, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C P CarmignaniP H Sugarbaker
Jun 1, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C PomelD Elias
Jul 2, 2003·Molecular Immunology·Walid SalamounDany Abi Gerges
Nov 30, 2000·Surgical Oncology·F C EilberF R Eilber
Oct 22, 2003·Surgical Oncology Clinics of North America·Olivier Glehen, François Noël Gilly
Oct 24, 2000·The British Journal of Surgery·J Esquivel, P H Sugarbaker
Aug 8, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E D HagerH Strama
Mar 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D EliasM Ducreux
Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M LookP H Sugarbaker
Jan 9, 2001·The Journal of Obstetrics and Gynaecology Research·J SehouliW Lichtenegger
Jun 4, 2005·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·F Alexander-SefreB Moran
Dec 17, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M LookP H Sugarbaker
Mar 3, 2004·Annals of Surgical Oncology·Dominique EliasMichel Ducreux
Apr 9, 2004·Annals of Surgical Oncology·Syed A AhmadAndrew M Lowy
May 29, 2009·Annals of Surgical Oncology·Laura A LambertPaul F Mansfield
Jan 25, 2006·Annals of Surgery·Manuel J KoppeRobert P Bleichrodt
Jul 27, 2010·The Oncologist·Thomas Winder, Heinz-Josef Lenz
Apr 21, 2011·Current Oncology·F MohamedP Sugarbaker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.